Sentante announced today that the FDA accepted its stroke treatment system into its Total Product Life Cycle Advisory Program (TAP).

A high-dose rehabilitation therapy improves motor outcomes in infants with perinatal stroke, offering rare evidence to guide ...

FDA-approved robots to tackle mobility disorders, paediatric autism, ADHD, cerebral palsy Dubai: A new advanced robotic rehabilitation centre coming up in Dubai will use 18 US FDA-approved robots that ...

An at-home brain-computer interface improves upper limb motor function in patients with chronic stroke, suggesting a new avenue for long-term neurorehabilitation.

Dr. Mehmet Oz, who heads the Centers for Medicare and Medicaid Services, is advancing a $50 billion plan to modernize rural ...

For many people, a voice is more than sound—it’s identity, independence, and connection. When illness, injury, or a congenital condition ...

Engineers at Washington University in St. Louis have developed a new class of protein-based fibers modeled on the aligned ...

Brainomix announced today that it added $6.5 million (£4.8 million) in an extension to its Series C financing round.

A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body. Occurring in 80% of stroke ...

Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...